Aditi P. Singh, MD

Medical Oncology
Accepting new patients
Sees patients age 18 and up
Abramson Cancer Center Perelman 2nd Floor West
Make an appointmentCall 215-615-5858
Headshot of Aditi P. Singh, MD
Penn Medicine Provider

About me

  • Assistant Professor of Clinical Medicine (Hematology-Oncology)

My education and training

  • Medical School: Lady Hardinge Medical College
  • Residency: University of Alabama Medical Center
  • Residency: Tufts - New England Medical Center
  • Fellowship: Montefiore Medical Center

Spoken languages

English
English
ਪੰਜਾਬੀ
Punjabi
हिन्दी
Hindi

Reviews

Average Rating

332 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

Anonymous
April 2026
i just like her !
Anonymous
April 2026
very professional
Anonymous
April 2026
great doctor
Anonymous
April 2026
trust this doctor completely

Insurance accepted

Please contact the practice and/or the member services department of your insurance company for specific details before receiving services. Providers may participate in some, but not all, products offered by a health plan; providers may also accept plans at some practice locations but not others.

Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
Dr. Singh is a Penn Medicine physician.

Qualifications and experience

Treatments and Conditions

Research

Publications

Aditi P Singh, Abigail T Berman, Melina E Marmarelis, Andrew R Haas, Steven J Feigenberg, Jennifer Braun, Christine A Ciunci, Joshua M Bauml, Roger B Cohen, John C Kucharczuk, Lawrence N Shulman, Corey J Langer, Charu Aggarwal Management of Lung Cancer During the COVID-19 Pandemic , JCO Oncol Pract, 16(9): 2020,579-586

Charu Aggarwal, Jeffrey C. Thompson, Austin L. Chien, Katie J. Quinn, Wei-Ting Hwang, Taylor A. Black, Stephanie S. Yee, Theresa E. Christensen, Michael J. LaRiviere, Benjamin A. Silva, Kimberly C. Banks, Rebecca J. Nagy, Elena Helman, Abigail T. Berman, Christine A. Ciunci, Aditi P. Singh, Jeffrey S. Wasser, Joshua M. Bauml, Corey J. Langer, Roger B. Cohen and Erica L. Carpenter Baseline Plasma Tumor Mutation Burden Predicts Response to Pembrolizumab-based Therapy in Patients with Metastatic Non–Small Cell Lung Cancer , Clin Cancer Res , 26(10): 2020,2354-2361

Aditi P. Singh, Elaine Shum, Lakshmi Rajdev, Haiying Cheng, Sanjay Goel, Roman Perez-Soler, Balazs Halmos Impact and diagnostic gaps of comprehensive genomic profiling in real-world clinical practice , Cancers, 12(5): 2020,1156

Qinfang Deng, Qiyu Fang, Hui Sun Aditi P. Singh, Mariam Alexander, Shenduo Li, Haiying Cheng, Songwen Zhou. Detection of plasma EGFR mutations for personalized treatment of lung cancer patients without pathologic diagnosis , Cancer Med, 9(6): 2020,2085-2095

Attarian S, Guo X, Ko B, Singh AP, Castellucci E, Gucalp R, Haigentz M, Cheng H, Halmos B. Lung cancer in patients with HIV - Unique features impacting lung cancer screening and management , World Lung Cancer Conference - Virtual Meeting: 2019

Singh AP, Alexander M, Goradia N, Cheng H Practical Advice for Treating Leptomeningeal Disease in Non–Small Cell Lung Cancer , The Journal of Targeted Therapies in Cancer, 26(9): 2018

Singh AP, Cheng H, Guo X, Levy B, Halmos B. Circulating Tumor DNA in Non–Small-Cell Lung Cancer: A Primer for the Clinician , Journal of Clinical Oncology/Precision Oncology : 2017

Singh AP, Li S, Cheng H. Circulating DNA in EGFR-mutated lung cancer. , Ann Transl Med, 5(18): 2017,379

Hardin C, Shum E, Singh AP, Perez-Soler R, Cheng H. Emerging treatment using tubulin inhibitors in advanced non-small cell lung cancer. , Expert Opin Pharmacother, 18(7): 2017,701-716

Puri Singh A, Haywood C Jr, Beach MC, Guidera M, Lanzkron S, Valenzuela-Araujo D, Rothman RE, Dugas AF. Improving Emergency Providers' Attitudes Toward Sickle Cell Patients in Pain. , J Pain Symptom Manage, 51(3): 2016,628-32